James Mastakas

James Mastakas currently serves as Chief Financial Officer at Rising Pharmaceuticals, overseeing finance, strategic planning, and acquisitions for a private equity-owned generic pharmaceutical company. Mastakas has held multiple senior leadership roles in the pharmaceutical industry, including Senior Vice President and Chief Operating Officer at Advantice Health, and Interim CEO at Virtus Pharmaceuticals. Previous positions include Senior Vice President and Chief Financial Officer at Amneal Pharmaceuticals and CorePharma LLC, as well as VP and Chief Financial Officer at Sandoz, where involvement extended to the North American division of Novartis. Earlier in their career, Mastakas served as Vice President - Controller at Mylan Pharmaceuticals and Director of External Reporting at Wyeth Pharmaceuticals. Knowledge in audit management was gained at Ernst & Young as an Audit Manager. James Mastakas earned a Bachelor of Science in Accountancy from Bentley University.